<DOC>
	<DOC>NCT00958243</DOC>
	<brief_summary>The purpose of this study is to evaluate the immunogenicity and safety profile of CSL425 (CSL's 2009 H1N1 influenza vaccine) in a healthy pediatric population.</brief_summary>
	<brief_title>A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male or female aged &gt;= 6 months to &lt; 9 years at the time of the first study vaccination. For children &lt; 3 years of age at the time of first vaccination, born at or after 36 weeks gestation. Known hypersensitivity to a previous dose of influenza virus vaccine or allergy to eggs, chicken protein, neomycin, polymyxin, or any components of the Study Vaccine</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>